The Bcr–Abl kinase regulates the actin cytoskeleton via a GADS/Slp-76/Nck1 adaptor protein pathway
- 1 May 2010
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 22 (5) , 848-856
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Charting the molecular network of the drug target Bcr-AblProceedings of the National Academy of Sciences, 2009
- Cell motility through plasma membrane blebbingJournal of Cell Biology, 2008
- Abi1 gene silencing by short hairpin RNA impairs Bcr-Abl-induced cell adhesion and migration in vitro and leukemogenesis in vivoCarcinogenesis, 2008
- Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFsOncogene, 2007
- Bcr-Abl induces abnormal cytoskeleton remodeling, β1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathwayJournal of Cell Science, 2007
- Reassembly of contractile actin cortex in cell blebsJournal of Cell Biology, 2006
- Mechanism of Blebbistatin Inhibition of Myosin IIJournal of Biological Chemistry, 2004
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Gads is a novel SH2 and SH3 domain-containing adaptor protein that binds to tyrosine-phosphorylated ShcOncogene, 1998
- BCR-ABL Induces Neurite-like Structures and BCR Lacking the SH2-Binding Domain Induces Cell Rounding in PC12 CellsExperimental Cell Research, 1996